Trademarkia Logo

Canada

C$
STAINED GLASS DESIGN
ADVERTISED

on 8 Nov 2024

Last Applicant/ Owned by

MERCK SHARP & DOHME LLC

126 East Lincoln Ave.P.O. Box 2000Rahway, NJ 07065

US

Serial Number

2061365 filed on 2th Nov 2020

Registration Number

TMA1268191 registered on 8th Nov 2024

Registration expiry Date

8th Nov 2034

Correspondent Address

BORDEN LADNER GERVAIS LLP

Bay Adelaide Centre, East Tower22 Adelaide St. WestTORONTO

ONTARIO

CA

M5H4E3

STAINED GLASS DESIGN

Trademark usage description

pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for the prevention and treatment of bone, c Read More

Vienna Information


7 . 3 . 2

Windows, window panes, stained-glass windowsFenêtres, vitres, vitraux

26 . 11 . 3

More than two lines or two bandsPlus de deux lignes ou de deux bandes

26 . 11 . 12

Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)

26 . 11 . 6

Thick lines, bandsLignes épaisses, bandes

26 . 1 . 1

CirclesCercles

26 . 1 . 3

One circle or ellipseUn cercle ou une ellipse

26 . 1 . 12

Circles or ellipses containing one or more other geometrical figures -- Note: Including circles or ellipses containing bent or straight lines (except 26.1.10).Cercles ou ellipses contenant une ou plusieurs autres figures géométriques -- Note: Y compris les cercles ou ellipses contenant des lignes courbées ou droites (excepté 26.1.10).

26 . 1 . 24

Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée

26 . 2 . 1

Segments of circles or ellipses (except 26.2.7)Segments de cercle ou d'ellipse (excepté 26.2.7)

26 . 2 . 24

Segments or sectors of circles or ellipses, semi-circles or semi-ellipses with dark surfaces or parts of surfacesSegments ou secteurs de cercles ou ellipses, demi-cercles ou demi-ellipses avec surface ou partie de la surface foncée

Classification Information


Class [005]
Pharmaceutical preparations and substances for use in Oncology; Pharmaceutical preparations and substances for the prevention and treatment of bone, cardiovascular, hematological, hepatological, immunological, gastrointestinal, musculoskeletal, nephrological, oncological, ophthalmic, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; Pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, namely bacterial skin infections, fungal skin infections, viral skin infections, parasitic skin infections, psoriasis, eczema, and dermatitis; Pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the endocrine system, namely, glucagonoma, growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; Pharmaceutical preparations and substances for the prevention and treatment of genitourinary diseases and disorders, namely, infertility, sexually transmitted diseases, inflammatory pelvic diseases; Pharmaceutical preparations and substances for the prevention and treatment of gynecological diseases and disorders, namely amenorrhoea, dysmenorrheal and diseases and disorders relating to sexual reproduction and fertility; Pharmaceutical preparations and substances for the prevention and treatment of metabolic diseases and disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, arthritis, obesity and hypothyroidism; Pharmaceutical preparations and substances for the prevention and treatment of pain; Pharmaceutical preparations and substances for the prevention and treatment of psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia, psychoses and bipolar disorders; Pharmaceutical preparations and substances for the prevention and treatment of Respiratory Syncytial Virus (RSV); Pharmaceutical preparations substances for the prevention and treatment of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, namely, dermatitis, skin pigmentation diseases, psoriasis, acne, rosacea, ichthyosis, urticaria and urinary incontinence; Pharmaceutical preparations, namely, antibiotics, anti-fungals, anti-infectives, anti inflammatories, anti-parasitics, and antivirals; Human vaccine preparations; Inhaled pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders


Classification kind code

11

Mark Details


Serial Number

2061365

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 42
on 21st Aug 2024
Advertised
Submitted for opposition 26
on 26th Jul 2024
Approved
Submitted for opposition 27
on 26th Jul 2024
Approval Notice Sent
Submitted for opposition 22
on 18th Jul 2024
Search Recorded
Submitted for opposition 48
on 15th Mar 2024
Agent Changed
Submitted for opposition 135
on 10th Aug 2022
Amendment to Application
Submitted for opposition 287
on 4th Aug 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 2th Nov 2020
Filed
Submitted for opposition 1
on 2th Nov 2020
Created
Submitted for opposition 31
on 2th Nov 2020
Formalized